Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pliant Therapeutics, Inc.

1.59
+0.11007.43%
Post-market: 1.590.00000.00%19:06 EDT
Volume:843.45K
Turnover:1.30M
Market Cap:97.60M
PE:-0.46
High:1.60
Open:1.46
Low:1.43
Close:1.48
Loading ...

Pliant Therapeutics Shares Fall 60.2% After Co Halts Enrollment in Mid-Stage Trial for Lung Disease Treatment

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
10 Feb

Pliant Therapeutics Inc : Wells Fargo Cuts Target Price to $4 From $41

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Inc : Wells Fargo Cuts to Equal Weight From Overweight

THOMSON REUTERS
·
10 Feb

Sector Update: Health Care Stocks Flat to Edging Higher Pre-Bell Monday

MT Newswires Live
·
10 Feb

Pliant Therapeutics Inc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues

Benzinga
·
10 Feb

Pliant Therapeutics Inc. : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
10 Feb

Top Premarket Decliners

MT Newswires Live
·
10 Feb

BUZZ-Pliant Therapeutics slumps as it halts enrollment in lung disease mid-stage trial

Reuters
·
10 Feb

Pliant Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
10 Feb

Piper Sandler Remains a Buy on Pliant Therapeutics (PLRX)

TIPRANKS
·
10 Feb

Pliant Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
10 Feb

Pliant Therapeutics Inc : H.c. Wainwright Cuts to Neutral Rating

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Shares Fall on Drug Trial Pause After Safety Board Review

Dow Jones
·
10 Feb

RBC Downgrades Pliant Therapeutics to Sector Perform From Outperform, Cuts Price Target to $4 From $45, Keeps Speculative Risk

MT Newswires Live
·
10 Feb

Pliant Therapeutics Inc : RBC Cuts to Sector Perform From Outperform

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Suspends Enrollment in Phase 2b Idiopathic Pulmonary Fibrosis Trial

MT Newswires Live
·
10 Feb

Pliant Therapeutics Falls 55.8% Premarket After Co Pauses Enrollment for Lung Disease Treatment Trial

THOMSON REUTERS
·
10 Feb

BUZZ-Pliant pauses enrollment for lung disease treatment trial

Reuters
·
08 Feb